StonvexLoading…
StonvexStonvexStonvexCore line items from ORN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $852.26M | $796.39M | $711.78M | $748.32M |
Operating Income | $14.61M | $11.52M | $-6.63M | $-8.03M |
Net Income | $2.49M | $-1.64M | $-17.88M | $-12.61M |
EPS (Diluted) | $0.06 | $-0.05 | $-0.55 | $-0.40 |
Total Assets | $414.65M | $417.32M | $416.89M | $367.15M |
Total Liabilities | $255.62M | $266.64M | $295.42M | $229.35M |
Cash & Equivalents | $1.59M | $28.32M | $30.94M | $3.78M |
Free Cash Flow OCF − CapEx | $-10.80M | $-1.42M | $8.27M | $-5.02M |
Shares Outstanding | 39.90M | 38.97M | 32.55M | 32.06M |